Skip to content

Tokushima Night Guard for Recurrent Aphthous Stomatitis

Effects of a Night Guard on Aphthous Stomatitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02890524
Enrollment
20
Registered
2016-09-07
Start date
2014-07-31
Completion date
2018-03-31
Last updated
2019-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphthous Stomatitis

Keywords

aphthous stomatitis, night guard, inflammatory cytokine

Brief summary

The investigators will investigate whether the night guard can suppress the development of recurrent aphthous stomatitis (RAS). The investigators will record the patients' oral condition for 60 days before and after intervention with the night guard made of Ethylene-Vinyl Acetate copolymer (EVA). The patients' saliva will be analyzed for measurement of inflammatory cytokines or oxidative stress.

Detailed description

The study involved 20 patients (8 male and 12 female) with RAS. These patients suffered from RAS at least once a month. The investigators will record their oral condition for 60 days before and after intervention with the night guard made of EVA. Their saliva will be analyzed for further studies including measurement of inflammatory cytokines or oxidative stress.

Interventions

DEVICEnight guard

60 days before and after intervention with the night guard

DEVICEplacebo night guard

60 days before and after intervention with the placebo night guard

Sponsors

University of Tokushima
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients suffered from recurrent aphthous stomatitis at least once a month

Exclusion criteria

* People do not have a experience of recurrent aphthous stomatitis

Design outcomes

Primary

MeasureTime frame
number of developed aphthous stomatitisthrough study completion, an average of 1 year

Secondary

MeasureTime frame
days until healingthrough study completion, an average of 1 year

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026